Funder: National Multiple Sclerosis Society
Due Dates (Anticipated): January 2027 (Full application)
Funding Amounts: Award budget and duration are specific to each RFA.
Summary: Supports targeted MS research addressing Society-identified gaps, with a planned winter 2026–2027 call on early detection and diagnosis.
Key Information: Postdoctoral fellows, residents, and other trainees are ineligible; commercial applicants qualify only when the RFA specifies.
Description
The National Multiple Sclerosis Society’s targeted Requests for Applications support focused research addressing gaps and high-priority directions identified through its Pathways to Cures Roadmap. Calls are released on an ad hoc basis, with each announcement defining its research scope, exclusions, budget, and award duration. Applicants are expected to bring their expertise and creativity to the objectives of the specific call.
For the winter 2026–2027 research funding cycle, the Society plans a targeted call addressing early detection and diagnosis of MS rather than an investigator-initiated opportunity. Previous calls have addressed aging, women’s health, depression self-management, remyelination and neuroprotection, functional recovery, viruses, compartmentalized inflammation, and detection before neurological deficits. These earlier topics illustrate the program’s range rather than the scope of the planned call.
